• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有位置性眩晕和乙酰唑胺反应性发作性共济失调的6型脊髓小脑共济失调

Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia.

作者信息

Jen J C, Yue Q, Karrim J, Nelson S F, Baloh R W

机构信息

Department of Neurology, UCLA School of Medicine, Los Angeles, California, USA.

出版信息

J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):565-8. doi: 10.1136/jnnp.65.4.565.

DOI:10.1136/jnnp.65.4.565
PMID:9771787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2170265/
Abstract

The SCA6 mutation, a small expansion of a CAG repeat in a calcium channel gene CACNA1A, was identified in three pedigrees. Point mutations in other parts of the gene CACNA1A were excluded and new clinical features of SCA6 reported--namely, central positional nystagmus and episodic ataxia responsive to acetazolamide. The three allelic disorders, episodic ataxia type 2, familial hemiplegic migraine, and SCA6, have overlapping clinical features.

摘要

在三个家系中发现了SCA6突变,即钙通道基因CACNA1A中的CAG重复序列小片段扩增。排除了基因CACNA1A其他部位的点突变,并报告了SCA6的新临床特征,即中心性位置性眼球震颤和对乙酰唑胺有反应的发作性共济失调。发作性共济失调2型、家族性偏瘫性偏头痛和SCA6这三种等位基因疾病具有重叠的临床特征。

相似文献

1
Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia.伴有位置性眩晕和乙酰唑胺反应性发作性共济失调的6型脊髓小脑共济失调
J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):565-8. doi: 10.1136/jnnp.65.4.565.
2
Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop.早发性进行性共济失调与在I-II环内鉴定出的首个CACNA1A突变相关。
J Neurol Sci. 2007 Mar 15;254(1-2):69-71. doi: 10.1016/j.jns.2007.01.008. Epub 2007 Feb 12.
3
Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2).乙酰唑胺可改善一个2型发作性共济失调(EA - 2)家系中的神经耳科异常。
J Neurol. 2004 Feb;251(2):232-4. doi: 10.1007/s00415-004-0299-1.
4
Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.由于19号染色体短臂上CACNA1A基因中的CAG重复序列扩增导致的发作性共济失调2型(EA2)和脊髓小脑共济失调6型(SCA6)。
Hum Mol Genet. 1997 Oct;6(11):1973-8. doi: 10.1093/hmg/6.11.1973.
5
Spinocerebellar ataxia type 6 and episodic ataxia type 2 in a Korean family.一个韩裔家族中的6型脊髓小脑共济失调和2型发作性共济失调
J Korean Med Sci. 2001 Dec;16(6):809-13. doi: 10.3346/jkms.2001.16.6.809.
6
Acetazolamide-Responsive Episodic Ataxia Linked to Novel Splice Site Variant in FGF14 Gene.乙酰唑胺反应性发作性共济失调与 FGF14 基因新型剪接位点变异相关。
Cerebellum. 2019 Jun;18(3):649-653. doi: 10.1007/s12311-018-0997-3.
7
De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia.CACNA1A基因的新发突变导致乙酰唑胺反应性发作性共济失调。
Am J Med Genet. 1998 May 26;77(4):298-301. doi: 10.1002/(sici)1096-8628(19980526)77:4<298::aid-ajmg9>3.0.co;2-j.
8
[A sporadic case of episodic ataxia with nystagmus (EA-2)].[一例伴有眼球震颤的发作性共济失调(EA-2)散发病例]
Rinsho Shinkeigaku. 1998 May;38(5):446-9.
9
Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo).1型和2型发作性共济失调(家族性周期性共济失调/眩晕)
Audiol Neurootol. 1997 Nov-Dec;2(6):373-83. doi: 10.1159/000259262.
10
[A clinical trial of acetazolamide for SCA6].乙酰唑胺治疗脊髓小脑共济失调6型的临床试验
Rinsho Shinkeigaku. 1999 Aug;39(8):793-9.

引用本文的文献

1
Central Pathologies Imitating Peripheral Causes of Vertigo.模仿周围性眩晕病因的中枢性病变
Indian J Otolaryngol Head Neck Surg. 2025 Feb;77(2):843-853. doi: 10.1007/s12070-024-05269-4. Epub 2024 Dec 8.
2
Downbeat nystagmus: a clinical and pathophysiological review.下跳性眼球震颤:临床与病理生理学综述
Front Neurol. 2024 May 24;15:1394859. doi: 10.3389/fneur.2024.1394859. eCollection 2024.
3
Potential Benefit of Channel Activators in Loss-of-Function Primary Potassium Channelopathies Causing Heredoataxia.通道激活剂在导致遗传性共济失调的功能丧失型原发性钾通道病中的潜在益处。
Cerebellum. 2024 Apr;23(2):833-837. doi: 10.1007/s12311-023-01584-8. Epub 2023 Jul 17.
4
CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options.与CACNA1A相关的通道病:临床表现及治疗选择
Handb Exp Pharmacol. 2023;279:227-248. doi: 10.1007/164_2022_625.
5
Evaluation of Cerebellar Ataxic Patients.小脑共济失调患者评估。
Neurol Clin. 2023 Feb;41(1):21-44. doi: 10.1016/j.ncl.2022.05.002. Epub 2022 Aug 31.
6
Current and emerging treatment modalities for spinocerebellar ataxias.脊髓小脑共济失调的当前和新兴治疗方法。
Expert Rev Neurother. 2022 Feb;22(2):101-114. doi: 10.1080/14737175.2022.2029703. Epub 2022 Feb 10.
7
Instrumented gait analysis defines the walking signature of CACNA1A disorders.仪器步态分析定义了 CACNA1A 障碍的行走特征。
J Neurol. 2022 Jun;269(6):2941-2947. doi: 10.1007/s00415-021-10878-y. Epub 2021 Nov 9.
8
Anticonvulsant Effects of Carbonic Anhydrase Inhibitors: The Enigmatic Link Between Carbonic Anhydrases and Electrical Activity of the Brain.碳酸酐酶抑制剂的抗惊厥作用:碳酸酐酶与大脑电活动之间神秘的联系。
Neurochem Res. 2021 Nov;46(11):2783-2799. doi: 10.1007/s11064-021-03390-2. Epub 2021 Jul 5.
9
The electrophysiological footprint of CACNA1A disorders.钙通道蛋白α1A亚基(CACNA1A)相关疾病的电生理特征
J Neurol. 2021 Jul;268(7):2493-2505. doi: 10.1007/s00415-021-10415-x. Epub 2021 Feb 5.
10
Evolution of the vestibular function during head impulses in spinocerebellar ataxia type 6.遗传性小脑共济失调 6 型中头脉冲试验时前庭功能的演变。
J Neurol. 2020 Jun;267(6):1672-1678. doi: 10.1007/s00415-020-09756-w. Epub 2020 Feb 17.